Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 0.23x is in line with its 1-year average of 0.25x, around the middle of its 1-year range (-0.27x–0.49x).
30.35% above its 12-month average of 0.18x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 0.27x.
INTEREST COVERAGE RATIO
0.23x
INTEREST COVERAGE RATIO AVG TTM
0.18x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+30.35%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.39x
median of 425 covered companies
CURRENT VS SECTOR MEDIAN
+104.27%
vs the sector median at left
Lumexa Imaging Holdings, Inc. Common Stock
Market Cap
$1.02B
Interest Coverage Ratio
0.23x
TTM Avg
0.18x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
Interest Coverage Ratio
0.79x
TTM Avg
0.59x
3Y Avg
2.04x
5Y Avg
2.37x
Market Cap
$1.01B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.03B
Interest Coverage Ratio
-192.41x
TTM Avg
28.86x
3Y Avg
28.86x
5Y Avg
28.86x
Market Cap
$1.00B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.04B
Interest Coverage Ratio
-497.79x
TTM Avg
15.03x
3Y Avg
15.03x
5Y Avg
8.31x
Market Cap
$998.79M
Interest Coverage Ratio
-8.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$999.73M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$997.31M
Interest Coverage Ratio
-28.96x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.02B | 0.23x | 0.18x | N/A | N/A |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 0.79x | 0.59x | 2.04x | 2.37x |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $1.01B | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.03B | -192.41x | 28.86x | 28.86x | 28.86x |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | -497.79x | 15.03x | 15.03x | 8.31x |
| MeiraGTx Holdings plc (MGTX)vs › | $998.79M | -8.69x | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $999.73M | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $997.31M | -28.96x | N/A | N/A | N/A |
| Janux Therapeutics, Inc. (JANX)vs › | $1.06B | N/A | N/A | N/A | N/A |
Interest Coverage
0.2x
Debt/Equity
1.59
Current Ratio
1.44
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 0.27x |
| 2026-03-31 | 0.28x |
| 2025-12-31 | -0.27x |
| 2025-09-30 | 0.42x |
| 2025-03-31 | 0.34x |
| 2024-12-31 | 0.49x |
